Cellular Biomedicine Group, Inc.
https://www.cellbiomedgroup.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cellular Biomedicine Group, Inc.
J&J CEO On Stereotypes, Innovation Secret Sauce And Kenvue
J&J chairman and CEO Joaquin Duato shares striking glimpses of his own life journey at a recent summit as he underscores the value of diversity, equity and inclusion. He also discusses the company’s formulae for innovation and the Kenvue spin out.
Janssen Gives Next-Gen CAR-Ts Another Shot After Fate Deal’s Collapse
A new collaboration with Cellular Biomedicine includes a CD19/CD20-directed bispecific CAR-T in Phase I development for B-cell non-Hodgkin lymphomas.
AstraZeneca Oncology R&D Head On China Biotech Innovation
AstraZeneca has been drawn back to drug development innovation in China after accelerating its rate of licensing deals with biotechs in the country over the past few months. Meanwhile, the UK multinational has also been building a network ecosystem together with a Chinese investment bank to take a long-term view in the country, a senior R&D executive told Scrip in an interview.
AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy
The UK major has been building its cell therapy portfolio for about three years internally, oncology R&D chief Susan Galbraith tells Scrip, and the purchase of Neogene and its TCR-Ts targeting neoantigens in solid cancers is a logical step.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
-
- Agreen Biotech Co. Ltd. China
- CBMG Holdings
- Cellular Biomedicine Group Ltd.
- Cellular Biomedicine Group (Wuxi) Ltd.
- Cellular Biomedicine Group (Shanghai) Ltd.
- Beijing Agreen Biotechnology Co., Ltd.
- Wuxi Cellular Biopharmaceutical Group Ltd.
- Eastbridge Investment Corporation
- Cellular Biomedicine Group Vax, Inc.
- Shanghai Cellular Biopharmaceutical Group Ltd.
- CBMG Shanghai
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice